US FDA Approves Less Frequent Lebrikizumab Dosing in AD The Dermatology Digest Source link
Codex Labs Secures Two US Patents for Steroid-Free Eczema Treatment Technology Dermatology Times Source link
In the Chair: Managing Nail Dystrophy in AD Dermatology Times Source link
Pediatric Pipeline Update: Key Approvals and Label Expansions You May Have Missed in 2026 Dermatology Times Source link